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Abstract
The hydantoin transporter Mhp1 is a sodium-coupled secondary
active transport protein of the nucleobase-cation-symport family
and a member of the widespread 5-helix inverted repeat superfamily
of transporters. The structure of Mhp1 was previously solved in
three different conformations providing insight into the molecular
basis of the alternating access mechanism. Here, we elucidate
detailed events of substrate binding, through a combination of
crystallography, molecular dynamics, site-directed mutagenesis,
biochemical/biophysical assays, and the design and synthesis of
novel ligands. We show precisely where 5-substituted hydantoin
substrates bind in an extended configuration at the interface of
the bundle and hash domains. They are recognised through hydro-
gen bonds to the hydantoin moiety and the complementarity of
the 5-substituent for a hydrophobic pocket in the protein. Further-
more, we describe a novel structure of an intermediate state of the
protein with the external thin gate locked open by an inhibitor,
5-(2-naphthylmethyl)-L-hydantoin, which becomes a substrate when
leucine 363 is changed to an alanine. We deduce the molecular
events that underlie acquisition and transport of a ligand by Mhp1.
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Introduction
Mhp1 from the Gram-positive Microbacterium liquefaciens is an
integral membrane protein that mediates the Na+-dependent
binding and uptake of 5-aryl-substituted hydantoins (Suzuki &
Henderson, 2006; Weyand et al, 2008). Hydantoins are important
compounds in salvage pathways for nitrogen balance in yeasts and
plants and are particularly interesting commercially for the synthesis
of chiral amino acids (Bommarius et al, 1998; Altenbuchner et al,
2001; Suzuki et al, 2005). Mhp1 belongs to the nucleobase-
cation-symport-1, NCS1, family of secondary active transporters
(Weyand et al, 2008) found widely in bacteria (de Koning & Diallinas,
2000), archaea (Ma et al, 2013), fungi (Pantazopoulou & Diallinas,
2007) and plants (Mourad et al, 2012; Witz et al, 2012; Schein et al,
2013). Transporters from the NCS1 family are also important in the
toxicity of the antifungal agent, 5-flucytosine (Paluszynski et al,
2006), and mutations in the proteins can lead to drug resistance
(Chen et al, 2011). Mhp1 is an excellent model system for eluci-
dating how substrates or inhibitors, including drugs, are recognised
at the molecular level and then taken up into cells by members of
the NCS1 transporter family.
Mhp1 is of more general significance because it is also structur-
ally homologous to other proteins in different subfamilies of a
superfamily of secondary transporters (Wong et al, 2012). These
include LeuT (Yamashita et al, 2005) of the neurotransmitter-
sodium-symport family (NSS), vSGLT of the solute-sodium-symporter
family (SSS) (Faham et al, 2008), BetP (Ressl et al, 2009) and CaiT
(Schulze et al, 2010; Tang et al, 2010) of the betaine-carnitine-
choline family (BCCT), and AdiC (Fang et al, 2009; Gao et al, 2009;
Kowalczyk et al, 2011), ApcT (Shaffer et al, 2009) and GadC
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(Ma et al, 2012) of the amino acid-polyamine-organocation family
(APC). Members of the NSS, SSS and APC families play important
roles in human physiology, being responsible for the accumulation
of molecules such as neurotransmitters, sugars, amino acids and
drugs into cells (Gether et al, 2006; Broer & Palacin, 2011; Wright,
2013). As for Mhp1, transport in LeuT, BetP and vSGLT is driven by
the cotranslocation of sodium ions (Abramson & Wright, 2009;
Perez & Ziegler, 2013), but the superfamily also contains many
examples of proton-coupled symporters or antiporters. The super-
family has been termed the 5-helix inverted repeat transporter
superfamily (5HIRT), as each protein has a core of ten transmem-
brane helices with pseudo twofold symmetry relating repeats of five
helices (Abramson & Wright, 2009). These proteins, like other
secondary transporters, utilise a mechanism described by the “alter-
nating access” model of membrane transport (Jardetzky, 1966) with
their similar structures implying commonalities of mechanism
(Abramson & Wright, 2009; Krishnamurthy et al, 2009; Forrest et al,
2011; Shi, 2013). In this model, conformational changes to the
protein alternately expose the substrate-binding site to the outside
or the inside of the cell. In switching between these two states, the
protein adopts one or more intermediate states, at least one of
which must be occluded. Mhp1 was the first secondary transporter
for which an outward, an inward and an occluded state was charac-
terised crystallographically, and this has provided much useful
insight into the mechanism of alternating access (Weyand et al,
2008; Shimamura et al, 2010; Weyand et al, 2011; Shi, 2013). Mhp1
was also used to model the outward-facing form of the human Na+-
glucose cotransporter in combination with the inward-facing form
of vSGLT (Sala-Rabanal et al, 2012).
The structure of Mhp1 comprises twelve transmembrane helices
(TMHs), which include the ten core TMHs characteristic of the
superfamily with an additional two at the C-terminus (Weyand
et al, 2008). The core can be divided into two motifs, a bundle
motif (TMHs 1, 2, 6 and 7) and a hash motif (TMHs 3, 4, 8 and 9)
(Shimamura et al, 2010). Two additional helices, TMHs 5 and 10,
link the bundle with the hash motif and the hash motif to the
C-terminal TMHs, respectively. Based upon structural data, the
currently accepted mechanism (Shimamura et al, 2010) involves
substrate binding to the outward-facing conformation of the trans-
porter in a cavity between the bundle and hash domains. The
N-terminal part of TMH10 then folds over the substrate to occlude
it in the binding site (Weyand et al, 2008). Subsequently, the protein
can switch to the inward-facing conformation by a predominantly
rigid body rotation of the hash domain relative to the bundle
domain (Shimamura et al, 2010). For sodium-coupled transporters,
the conformational changes have been described in terms of the
opening and closing of thick and thin gates (Krishnamurthy et al,
2009); in Mhp1, TMHs 5 and 10 correspond to the intra- and
extracellular thin gates, respectively, and the rotation of the hash
motif relative to the bundle corresponds to the movement of the
thick gate. The binding site for sodium ions is located at the inter-
face between the bundle and hash motifs and is only fully formed
in the outward-facing structures.
Although the previously solved structure of Mhp1 in complex with
L-5-benzylhydantoin (L-BH) was sufficient to reveal where the
substrate binds and how the movement of TMH10 is able to occlude
the binding site, the details of these events were obscure. Here, we
elucidate the structural basis of ligand binding to Mhp1 and the conse-
quent movements of individual amino acids and overall conforma-
tional changes using a combination of X-ray crystallography,
molecular dynamics, site-directed mutagenesis, ligand design,
synthetic chemistry and biochemical/biophysical assays. We characte-
rise L-5-(2-naphthylmethyl)hydantoin (NMH) as a non-transported
inhibitor of Mhp1 and show how the structure of the Mhp1-NMH
complex provides insight into the role of TMH10 in transport.
Results
Crystal structures of Mhp1-hydantoin complexes
The structure of Mhp1 in complex with L-5-(1H-indol-3-ylmethyl)
hydantoin (L-IMH) was determined at 3.4 A˚ resolution (Table 1). The
L-IMH ligand is clearly defined in the electron density, residing
between the bundle and hash motifs (Fig 1A and B, and Supplemen-
tary Fig S1A). Although the position of L-IMH is similar to that of
L-BH in the previously reported structure, the higher-resolution and
better quality maps associated with the new structure enabled signifi-
cant improvement in our understanding of ligand binding. L-IMH
binds in amore extended conformation thanwas previously modelled
for L-BH with the hydantoin ring reoriented by 180°. The hydantoin
moiety mainly interacts with residues on the hash motif. It lies
approximately parallel to the indole ring of Trp117 such that the two
aromatic groups form a face-to-face p-stacking interaction and
appears to be oriented by hydrogen bonding interactions with
Asn318, Gln121 and Gly219 (Fig 1B–D). This latter interaction with
Gly219 at the breakpoint of TMH6 on the bundle was not apparent
previously.
The indole moiety of L-IMH packs between the main chain of
Gly219 and the side chain of Gln42 at the breaks of the bundle heli-
ces TMH6 and TMH1, respectively, and forms an edge-to-face
p-stacking interaction with Trp220 (Fig 1B–D). Overall, this region
of the Mhp1 protein forms a hydrophobic pocket that accommodates
the indole moiety of the hydantoin as shown in the surface repre-
sentation in Fig 1C.
To confirm unambiguously the orientation of the 5-aryl substi-
tuted ligands, the structure of Mhp1 was also solved as a complex
with the bromine-containing (5Z)-5-[(3-bromophenyl)methylidene]
hydantoin (BVH). Data were collected at the bromine edge, and the
structure was refined at 3.7 A˚ (Table 1). BVH binds in a very similar
position and orientation to L-IMH with the bromine clearly defined
in anomalous difference maps (Supplementary Fig S1C).
Glossary
Mhp1 Microbacterium hydantoin permease 1
BH 5-benzyl-L-hydantoin = (5S)-5-benzylimidazolidine-2,4-dione
BVH 5-bromovinylhydantoin = (5E)-5-[(3-bromophenyl)methylidene]
imidazolidine-2,4-dione
IMH 5-indolylmethyl-L-hydantoin = (5S)-5-(1H-indol-3-ylmethyl)
imidazolidine-2,4-dione
NMH 5-(2-naphthylmethyl)-L-hydantoin = (5S)-5-(naphthalen-2-
ylmethyl)imidazolidine-2,4-dione
All allantoin = 5-ureidohydantoin = (2,5-dioxo-4-imidazolidinyl)
urea
Hyd hydantoin = imidazolidine-2,4-dione
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Having refined the IMH-Mhp1 and BVH-Mhp1 complexes, we
also re-examined the BH-Mhp1 complex. Refinement was carried
out against new data at a resolution of 3.8 A˚ (Table 1). The
improved electron density indicates that L-BH binds in an extended
mode (Fig 1E and F, and Supplementary Fig S1B) similar to L-IMH
rather than the “U-shaped” folded conformation seen in the crystal
structure from the small molecule database (Delgado et al, 2007),
which was modelled previously (Weyand et al, 2008). The benzyl
ring of L-BH overlaps the centre of the indole of L-IMH in a struc-
tural superposition within the hydrophobic binding pocket (Fig 1C
and E, and Supplementary Fig S1A and B).
We next examined the conformational changes that occur upon
binding of ligands to Mhp1 and that can be interpreted at the
modest resolution of the ligand complexes.
Comparison of outward-open and occluded structures
A number of conformational differences within Mhp1 can be
observed between the ligand-free outward-open and the ligand-
bound occluded structures upon binding of all three ligands, L-IMH,
L-BH and BVH (Fig 1A and B). Firstly, the hash domain rotates ~5°
inwards relative to the bundle around an axis approximately parallel
to TMH8 moving Trp117, Gln121 and Asn318 towards the hydan-
toin portion of the substrate (Fig 1A and B, arrow A). In addition,
the side chains of Trp117 and Trp220 swivel to sandwich the
substrate in the binding site (Fig 1B, arrows B and C). Gln121 in its
new position is closer to and could potentially form a hydrogen
bond with Gln42, whereas these two residues are 3.7 A˚ apart in the
outward-open structure. TMH10, TMH11 and TMH12 follow the
hash motif to some extent with TMH10 bending near to Ala369 to
occlude the substrate in the binding site (Fig 1A and B, arrow D).
During these transitions, the sodium ion binding site does not
appear to change appreciably.
Due to the relatively low resolution of the data for the ligand
complexes and the consequent uncertainty in the exact positions of
the side chains, the plausibility of the proposed hydrogen bonds to
the hydantoin moiety of the ligand was tested by conducting simula-
tions of the occluded conformation of Mhp1 with the L-BH and
L-IMH substrates.
Molecular dynamics simulations confirm the hydrogen bonding
of Mhp1 to an extended configuration of the ligand
First, we examined conformational flexibility of the substrates both
in water and bound to Mhp1 using molecular dynamics simulations
(see Materials and Methods and Supplementary Methods). In solu-
tion, L-BH switches freely between three major conformers, two
extended forms and one U-shaped (Fig 2A), as the free energy
differences between them are small and the barriers are only of
moderate size (< 9 kT) (Supplementary Fig S2). Similar results are
observed for L-IMH, although the extended conformations are actu-
ally favoured (Fig 2B). In contrast, when bound to Mhp1, L-BH and
L-IMH become locked into an extended conformation (Supplemen-
tary Fig S3A–C, I–K), even if starting from an initial U-shaped
Table 1. Statistics for the X-ray diffraction analyses.
L-IMH L-BH BVH D/L-NMH
Beamline Diamond I02 Diamond I03 Diamond I03 Diamond I04
Wavelength (Å) 0.9795 0.97630 0.91910 0.9795
Resolution (Å)a 3.4 (3.49-3.4) 3.8 (3.87-3.8) 3.7 (3.76-3.7) 3.7 (3.8-3.7)
Space group P212121 P212121 P212121 P212121
Cell dimensions (Å) 87.4 106.4 100.6 95.6 106.7 107.9 90.0 107.3 109.3 87.6 106.9 106.8
No. measured reflections 49,523 47,500 52,691 35,592
No. unique reflections 12,215 10,629 11,569 10,714
Completeness (%) 92 (87) 97 (96) 98 (98) 96 (96)
Redundancy 4.1 (3.8) 4.5 (3.8) 4.6 (3.7) 3.3 (2.8)
I/r(I) 13.2 (1.2) 12.4(1.7) 15(2.0) 8.3(2.0)
Rmerge 0.054 (0.882) 0.097 (0.698) 0.066 (0.533) 0.063 (0.686)
CC(1/2) highest resolution shell 0.72 0.83 0.77 0.7
CC(1/2)b < 0.5: a*; b*; c* (Å) 3.9; max; 3.7 5.6; max; 5.3 4.4; max; 5.1 4.7; max; 5.1
Rfactor(%) 24.8 28.4 25.7 25.6
Rfree
c (%) 28.3 30.8 28.8 30.8
rms deviations from ideal values
Bonds (Å) 0.007 0.007 0.005 0.008
Angle (°) 1.2 1.0 1.1 1.3
Ramachandran outliers (%)d 0.7 0.2 0.4 0.7
aValues in parentheses refer to data in the highest resolution shell.
bthis is the CC(1/2) where the resolution drops below 0.5 as reported by aimless (Evans & Murshudov, 2013).
c
5% of test reflections.
das defined in MolProbity (Chen et al, 2010).
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A B
C
E F
D
Figure 1. Binding of substrates in Mhp1.
A, B Superposition of the outward-open structure (PDB code 2JLN) onto the IMH-bound structure, optimised using the bundle helices. The IMH structure is shown with
the bundle in red, the hash motif in yellow, TMHs 5 and 10 in blue and the C-terminal helices in magenta. The outward-open structure is shown in grey. The
L-IMH (green spheres) and sodium ion (magenta) bind between the hash and bundle motifs. (A) shows an overview of all helices and (B) a close up. The arrows
show the main conformational changes that occur upon L-IMH binding. Arrow A: the hash motif rotates towards the bundle with the C-terminal helices partially
following. Arrows B and C: Trp117 and Trp220 rotate towards the hydantoin moiety and the 5-indole substituent, respectively, of L-IMH. Arrow D: TMH10 flexes and
packs over the IMH.
C The extended form of L-IMH in the binding site illustrated using the SPROUT format (Materials and Methods and Supplementary Methods) to show the indole
moiety in a hydrophobic pocket (green).
D Schematic of interactions made between L-IMH and the protein. Possible hydrogen bonds are indicated by straight dashed lines and hydrophobic interactions by
curved dashed lines.
E The extended form of L-BH is oriented similarly to L-IMH with its benzyl moiety in the hydrophobic pocket.
F Schematic of the interactions made by L-BH with Mhp1.
Data information: In (C and E) green represents regions where a hydrophobic interaction can be made, blue represents regions containing hydrogen-bond donor atoms,
and red represents regions containing hydrogen-bond acceptor atoms.
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conformation (Supplementary Fig S3E–H). The transition to the
extended conformation typically occurs rapidly within the first
20 ns of the simulation.
The most frequently observed hydrogen bonds across the simula-
tions with the Mhp1 ligand-occluded form are: a two-pronged inter-
action between one N/O face of the hydantoin ring with Asn318;
between N1 of the hydantoin and the backbone of Gly219; and
partially between O4 of the hydantoin and Gln121 (Fig 2D and E).
The remaining oxygen in the hydantoin moiety tends to be solvated
by water, with the region near TMH8 being the only fully solvated
part of the binding site (Fig 2D and E). On the limited time scale of
the simulations, hydrogen bonds to Gln42 were not observed with the
crystallographically observed conformer. In a single simulation, the
hydantoin moiety rotated by 180 and adopted an alternative binding
mode that included a transient hydrogen bond between the hydan-
toin and Gln42 instead of the persistent bond to Gly219 [IMH(g-):
MD_001 in Fig 2F and Supplementary Fig S3i]. Across the simula-
tions, a common pattern emerges (Fig 2D–F and Supplementary
Fig S3) whereby an extended conformation of the ligand is required so
that the hydantoin ring can hydrogen bond simultaneously to Asn318
and Gly219. Overall, the simulations corroborate the existence of the
proposed H-bonds to Asn318, Gly219 and possibly Gln121.
After identifying the overall conformational changes of Mhp1
upon binding of ligand, we sought to establish the roles of individual
residues in ligand binding using a site-directed mutagenesis
approach.
The roles of individual residues of Mhp1 in ligand binding
and transport
The effect of mutating individual residues, especially those
suggested to interact with the ligands in the above structures and
simulations, was investigated. Changes were monitored in the
uptake of radioisotope-labelled substrates into cells and in the direct
binding of ligands to purified protein, measured using spectrophoto-
fluorimetry (Materials and Methods).
Replacement of the completely conserved Asn318 with an
alanine led to a significant loss of uptake activity (Fig 3 and Supple-
mentary Table S1) and a substantial reduction in binding (Supple-
mentary Table S1 and Supplementary Fig S4) as might be expected
from the loss of the bidentate hydrogen bonding arrangement seen
in the structure (Fig 1). The conservative mutation of Gln121 to
asparagine resulted in partial decreases in efficiency of both uptake
and binding (Fig 3, Supplementary Table S1 and Supplementary Fig
S4), while its replacement with leucine, as is observed in the uridine
transporter Fui1 (de Koning & Diallinas, 2000; Weyand et al, 2008),
reduced uptake and binding yet further. This is again consistent
with the hydrogen bonding interaction proposed from the structures
and simulations (Figs 1 and 2).
Gly219 of Mhp1 is not well conserved amongst NCS1 family
members, but in Mhp1, it is a key component of the break in TMH6
that contributes to accommodation of the ligand; in addition, its
carbonyl oxygen forms a hydrogen bond with the L-IMH. Substitu-
tion of this residue with serine or isoleucine as seen in other NCS1
transporters reduced both binding and transport activity (Fig 3,
Supplementary Table S1 and Supplementary Fig S4), with the more
bulky isoleucine having a more pronounced effect as would be
expected. In the IMH-Mhp1 crystal structure, there is very limited
space available in the region of Gly219 such that substitution of this
glycine with any other amino acid would result in a clash of the
amino acid side chain with the indole ring of L-IMH.
Trp117 and Trp220 sandwich L-IMH in the binding pocket. The
aromatic ring of Trp117 seems to be important for uptake because
activity is reduced dramatically if this residue is replaced by an
alanine but only moderately when changed to a phenylalanine
(Fig 3 and Supplementary Table S1). Surprisingly, the change of
Trp220, either conservatively to phenylalanine, or more drastically
to alanine, had little effect on uptake (Fig 3 and Supplementary
Table S1), despite the conservation of this residue in aligned NCS1
transporters.
From measurements of uptake and binding activities with the
Gln42Asn and Gln42Leu mutants (Fig 3 and Supplementary Table
S1), this residue would appear to play an important role in the
mechanism of Mhp1, but the basis for this is not obvious from the
crystal structure or molecular dynamics simulations. Gln42 is within
van der Waals interaction distance of the aromatic rings of L-IMH
and L-BH and in fact was difficult to position in the crystal structure
due to the close interaction between the protein and ligand atoms. It
is not within hydrogen bonding distance of any atom from L-IMH,
although the side chain can potentially interact with the p electrons
of the indole ring. Instead, it forms a hydrogen bonding interaction
with Gln121 (Fig 2E). Shortening the side chain by mutating Gln42
to asparagine resulted in modest decreases in uptake and binding
efficiency, while the respective reductions were greater when Gln42
was replaced with phenylalanine or leucine (Fig 3, Supplementary
Table S1 and Supplementary Fig S4). While the replacement with a
bulky hydrophobic group presumably causes steric hindrance
preventing the substrate from binding, mutation to asparagine could
result in a reduction of affinity either as a direct result of the loss of
the interaction with the ligand or a disruption of the hydrogen bond-
ing interaction with Gln121. As neither Gln121 nor Gln42 are
conserved amongst the wider NCS1 family, it seems unlikely that
this latter interaction is instrumental in inducing the conformational
changes necessary for switching the transporter from outward to
inward facing, or indeed other conformational changes, such as
inward to outward facing. A possible role for Gln42 is in shaping
the binding pocket to enable the substrates to bind although we
cannot exclude that it affects the binding of the nearby sodium ion.
The above crystal structures, simulations and mutagenesis stud-
ies strongly suggested that the hydrogen bonding network with the
hydantoin moiety is critical for binding. We then sought to expand
our understanding of the interactions between the protein and its
substrates using molecular modelling and synthetic chemistry to
generate new ligands for Mhp1.
The structure–activity relationship of ligands binding to Mhp1
To investigate the structure–activity relationship of potential
ligands, we tested their binding to Mhp1 by measuring inhibition of
14C-L-IMH uptake into whole cells. We first tested known substrates
of the related NCS1 transport proteins, including allantoin, adeno-
sine, uracil, guanosine, cytosine, thiamine and nicotinamide ribo-
side (Supplementary Fig S5). Allantoin contains a hydantoin moiety
but, surprisingly, did not show any inhibition of transport activity
by Mhp1 (Fig 4A). All of the other compounds, which do not have
this moiety, produced very weak or no inhibition (Supplementary
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Fig S5). Hydantoin was found to reduce the uptake of the radio-
labelled IMH (Fig 4A, Table 2 and Supplementary Fig S5), much
less than either L-BH or L-IMH, implying that the substituent in
position 5 plays an important role. Thus, apparently the hydantoin
moiety is required, but is not sufficient on its own for effective bind-
ing to Mhp1.
Next, we explored the structure–activity relationship of the
5-substituent moiety of the ligand with the choice of compounds
guided by docking algorithms (Materials and Methods; Supplemen-
tary Methods). The crystal structures showed that the indolylmethyl
or benzyl group of the original substrates binds in a large hydropho-
bic pocket bounded primarily by residues Ile45, Phe216, Gly219 and
A
D F
E
B C
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Trp220 (Fig 1). Docking studies suggested that the naphthyl moiety
of NMH would fit into the hydrophobic pocket (Fig 5A). In fact, this
molecule displayed the most effective inhibition of 14C-L-IMH
uptake of all compounds tested (Fig 4A and B, Table 2 and Supple-
mentary Fig S5). Overall, both the inhibitions of uptake and the
apparent affinities of Mhp1 for selected ligands, measured using
fluorimetry, decreased in the order NMH > BVH > IMH > BH (Fig 4A
and B, Table 2 and Supplementary Fig S5). These assays also
showed that Mhp1 generally binds the L-enantiomers of 5-substituted
hydantoins with higher affinity than the respective D-enantiomer
(Table 2, Fig 4A, and Supplementary Fig S5) (Suzuki & Henderson,
2006). For NMH, however, the two enantiomers bind with affinities
that are indistinguishable within the experimental error (Fig 4A
and B, Table 2 and Supplementary Fig S5).
Having identified NMH as the compound with the tightest bind-
ing to Mhp1 as measured in the inhibition and binding assays (sum-
marised in Table 2), we sought to establish the details of its
interaction with the protein using crystallography.
Crystal structure of Mhp1 with bound NMH
Mhp1 was cocrystallised with racemic NMH, and the structure of
the resulting complex was refined at 3.7 A˚ (Table 1). Electron
density was observed in the ligand binding site, consistent with the
extended forms of both the L- and D-enantiomers of NMH (Supple-
mentary Figs S1D and S7). The hydantoin moieties of both enantio-
mers make similar interactions to those seen for L-IMH and L-BH
(Fig 5B–D), and the naphthyl groups of each enantiomer substan-
tially occupy the hydrophobic pocket between TMHs 1 and 6, even
more so than the benzyl and indolylmethyl groups of L-BH and
L-IMH, which is consistent with the predictions from the docking
studies (Figs 1C and E and 5A).
Upon binding NMH, the protein undergoes similar conforma-
tional changes to those described above for the L-IMH-bound state
with a movement of the hash domain relative to the bundle and a
rotation of the two tryptophans (Fig 5B). Rather surprisingly,
however, TMH10 remains in the open position. If TMH10 were to
adopt the same conformation that is observed in the complex with
IMH, then Leu363 may clash with the naphthyl ring of NMH (3 A˚
distance in the low-resolution crystal structure) (Fig 5B). Thus, the
bulky naphthyl substituent appears to interfere with the formation
of the occluded conformation of TMH10.
NMH is an inhibitor and not a substrate for Mhp1
The observation that TMH10 was in the open position in the
complex with NMH suggested that NMH may act as an inhibitor
rather than a substrate. Were this to be the case, it was hypothes-
ised that removing the proposed steric clash at Leu363 (Fig 5B) by
mutating the protein could restore transport of NMH. This was
investigated by synthesising radio-labelled L-NMH and comparing
its uptake with those for other radio-labelled substrates (see Materials
and Methods, Supplementary Methods and Fig 4C).
Consistent with its action as an inhibitor rather than a substrate
no significant uptake of L-NMH into wild-type cells was observed
(Fig 4C), despite this compound inhibiting L-IMH uptake very
substantially (Fig 4A and B, Table 2). In contrast, when Leu363 was
mutated to an alanine, uptake was restored (Fig 4C), substantiating
Figure 2. Molecular dynamics simulations of Mhp1 and its ligands.
A–C Molecular conformations and conformational free energy landscape of L-BH, L-IMH and L-NMH in aqueous solution suggested by molecular dynamics simulations
L-BH (A), L-IMH (B) and L-NMH (C) in solution: The conformation of the hydantoin derivatives are described by the dihedral angles v1 and v2 as indicated in the
insets. The most probable conformations are indicated by the minima in the free energy of the system (in kT) as a function of the dihedral angles. Regions not
sampled by the equilibrium simulations are white; other possible minima would be separated by barriers larger than 6 kT from the accessible regions.
D–F Hydrogen bonds between substrates and Mhp1 as seen in MD simulations. The ligand and important residues are shown as sticks with hydrogen bonds as broken
black lines. Helices TM1 and TM6 from the bundle are in red and TM3 and TM8 from the hash motif in yellow (parts of TM3 were removed for clarity); a sodium ion
in the Na2 site is visible in the background. Water density is shown as a cyan mesh, contoured at 1.5 times the bulk value. Equivalent atoms on the ligands are
labelled. (D) L-BH [from simulation 5FH(g+)MD_002]. (E) L-IMH [from simulation IMH(g–)MD_002]. (F) Clustered fingerprint analysis of hydrogen bonds. The
occupancy (average number of hydrogen bonds between ligand atoms and protein or solvent atoms) from all MD simulations was clustered to show the most
commonly occurring hydrogen bonding patterns. Rows describe individual hydrogen bonds (identified by donor and acceptor heavy atom) while columns label
individual simulations; hydrogen bonds labelled in red were also seen in the crystal structures and in docking while blue ones indicate bonds to water molecules
present in the simulation. The ligand is denoted in the simulation name as either 5FH (L-BH) or IMH (L-IMH) together with the starting conformation of the v1
dihedral angle and the simulation number within the set. Chemically equivalent ligand atoms are treated as the same in the analysis (indicated by the generic
label “LIG” instead of “5FH” or “IMH”). Hydrogen-bonded water molecules are also treated as chemically equivalent (“SOL” for solvent).
◀
Figure 3. Impairment of hydantoin uptake in mutants of Mhp1.
The accumulation of 14C-L-IMH (50 lM initial external concentration) was
measured for 15 s in cells expressing the wild-type or mutant Mhp1 proteins
(Materials and Methods and Supplementary Methods). All measurements were
normalised to percentages by comparison with the wild-type value of
0.57  0.01 (s.e.m., n = 34) nmol/mg dry mass. Error bars represent the s.e.m. of
at least triplicate measurements. All assays were performed in the presence of
150 mM NaCl.
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our hypothesis, based on the crystal structure, that TMH10 must
occupy a defined closed position for transport to occur.
Discussion
Here, we have determined the structure of Mhp1 with four different
5-substituted hydantoin derivatives, L-IMH, L-BH, BVH and D/L-
NMH. The combination of improved maps due to higher-resolution
data along with anomalous difference maps derived from the bromo-
substituted compound BVH has allowed us to assign unambiguously
the position and orientation of the ligands. Furthermore, the exis-
tence and nature of hydrogen bonds stabilising the hydantoin moiety
and the importance of a hydrophobic pocket accommodating an
extended conformation of a 5-substituent have been substantiated by
a combination of mutagenesis, molecular dynamics simulations and
comparison of binding efficiencies of different ligands. Ligands with
a hydantoin moiety bind with higher affinity than those with other
nucleobase-like entities. This specificity is conferred by hydrogen
bonding interactions with Asn318 and Gln121, which are conserved
residues on the hash motif, and with the carbonyl oxygen of Gly219
located at the breakpoint of TMH6 on the bundle. In addition, the
conserved Trp117 residue of the hash motif forms an important
p-stacking interaction with the hydantoin moiety. Similar results
were also obtained for other NCS1 members, the eukaryotic purine–
cytosine transporter, FcyB from Aspergillus nidulans (Krypotou
et al, 2012) and the plastidic nucleobase transporter from Arabidopsis
thaliana, PLUTO (Witz et al, 2014). In these studies, which were
based on the structure of Mhp1, the equivalent residues to Trp117,
Asn318 and Gln121 were all shown to be important for substrate
binding, although the magnitude of the effect varied amongst the
proteins. The specificity for the 5-substituent appears to be less strict
because a range of hydantoin derivatives can bind to Mhp1. Never-
theless, the clear preference for larger, more extended hydrophobic
and aromatic moieties can be explained by the hydrophobic pocket
located predominantly within the bundle region of the protein,
between TMHs 1 and 6. Most importantly, both the hydantoin and
5-substituent groups are necessary for tight binding and uptake.
Sodium ions binding at the interface between the hash motif and
the bundle have been postulated to favour the formation of the
outward-facing state (Weyand et al, 2011), as has been measured
by single molecule FRET for LeuT (Zhao et al, 2011) and conjec-
tured for other superfamily members (Abramson & Wright, 2009;
Krishnamurthy et al, 2009; Perez & Ziegler, 2013). In this conforma-
tion, the protein would be ready to accept the substrate. In the
sodium-bound outward-open form of Mhp1, there is a clear cavity for
the substrate to enter and bind although the residues involved in
binding are not in optimal positions to accommodate the ligand.
Instead, the substrate induces a number of conformational changes in
the protein. Firstly, there is a rigid body rotation of the hash domain
relative to the bundle bringing the conserved Trp117 and Asn318
closer to the substrate (Fig 6). Secondly, Trp117 and Trp220 each
rotate slightly to pack onto the hydantoin and hydrophobic moieties
of the ligand, respectively (Fig 6). These changes have consistently
been observed in all four Mhp1–ligand complexes presented here. The
next conformational change is caused by the packing of TMH10 onto
the substrate (Fig 6). Although this change was reported previously,
we are now in a position to discuss its significance in more depth.
In the outward-open ligand-free structure, TMH10 is relatively
straight, but when substrate binds, it bends over the substrate,
occluding it in the binding site (Fig 1A). Molecular dynamics simu-
lations have suggested that when the protein is outward facing, this
A B C
Figure 4. Ligand specificity of Mhp1 determined by uptake assays.
A, B Accumulation of 14C-L-IMH (50 lM initial external concentration) into wild-type cells was measured for 15 s (Materials and Methods and Supplementary Methods):
(A) in the presence of 500 lM of the indicated unlabelled compound; and (B) dose–response data for 14C-L-IMH uptake in the presence of 0–500 lM of selected
unlabelled compound. All measurements were normalised to percentages by comparison with the wild-type value of 0.57  0.01 (s.e.m., n = 34) nmol/mg dry
mass, and the error bars represent the s.e.m. of at least triplicate measurements.
C Uptakes of the indicated radioisotope-labelled compounds (50 lM initial external concentration, Materials and Methods and Supplementary Methods), into wild-
type cells were measured for 15 s for the original Mhp1 protein and for the L363A mutant as indicated at least in triplicate on each of two cell preparations and the
s.e.m. calculated for at least six assays. Hyd = hydantoin; All = allantoin. L-tryptophan and D/L allantoin were tested as controls in both (A) and (C).
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Table 2. Impairment of 14C-L-IMH uptake by selected ligands and their binding by Mhp1
Compound Structure Residual uptake (%) Apparent IC50 (lM) Apparent Kd (lM)
D-NMH
H
N
N
H
O
O
11.4  0.9 17.1  1.1 1.8  0.3
L-NMH
H
N
N
H
O
O
12.3  0.8 14.9  1.1 3.6  0.8
BVH Br
H
N
N
H
O
O
18.0  0.7 38.8  1.1 2.0  0.2
L-IMH
NH
H
N
N
H
O
O
24.7  1.3 119.2  1.1 19.0  2.0
D-IMH
NH
H
N
N
H
O
O
39.9  1.5 ND 20.6  3.8
L-BH H
N
N
H
O
O
59.9  1.7 945.0  1.1 36.0  1.4
D-BH H
N
N
H
O
O
70.9  4.1 ND 130.0  10.0
Hydantoin H
N
N
H
O
O
87.4  2.8 ND NC
L-Tryptophan
NH
H2N
HO
O
100.3  2.2 ND ND
D/L-Allantoin
NH
H2N
HO
O
101.9  2.3 ND NC
Percentage uptake and apparent IC50 values were determined by a
14C-L-IMH ligand uptake assay, and apparent Kd values were determined by stopped-flow
spectrophotofluorimetry. All measurements were taken in the presence of 150 mM NaCl (see Materials and Methods and Supplementary Methods) and are
shown with the associated standard errors of the mean. NC denotes “not converged” indicating that an apparent Kd or IC50 value could not be determined by
fitting to a rectangular hyperbola. ND denotes “not determined”.
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helix is in equilibrium between open and closed states (Shimamura
et al, 2010; Adelman et al, 2011; Shi, 2013). The crystallographic
data reported here are in agreement with these studies but further-
more suggest that TMH10 switches between discrete favourable
states. When the putative natural substrates, that is, L-IMH or L-BH
are bound, TMH10 is in the closed position (Fig 6); however, when
the slightly bulkier NMH is present in the binding site, the helix
retains the conformation seen in the ligand-free structures (Fig 6).
The results from radioactive transport assays demonstrate that the
Leu363Ala mutation changes NMH from an inhibitor into a
substrate. This suggests that a steric clash between Leu363 and the
bulky naphthyl group of NMH (Figs 5B and 6) prevents this compound
from being transported. Hence, only when TMH10 is completely
closed can transport be effected. Thus, it can be conjectured that
once Na+ and substrate have bound, it is the closure of the thin
gates that triggers the transition to the inward-facing conformation.
Presumably, although TMH10 is mobile when in the outward-open
ligand-free state, it cannot adopt the required conformation neces-
sary for transition to the inward-facing conformation if the other
conformational changes that accompany substrate binding do not
occur. At the resolution of the crystal structures, the sodium ion is
not clearly defined and it is difficult to discuss further how the
sodium ion binding site is affected by the presence of the substrate.
As more structures are solved of members of the 5HIRT super-
family, we are accumulating more information about the similarities
and differences in their mechanisms of transport (Shimamura et al,
2010; Krishnamurthy & Gouaux, 2012; Perez et al, 2012; Shi, 2013).
Although the location of the substrate-binding site between the
bundle and hash motif is similar in all of these structures, the exact
binding mode of the diverse substrates varies. While we show here
that the substrates form hydrogen bonding interactions mainly with
the hash motif in Mhp1, in the other structures, most specific inter-
actions are observed with the bundle motif (Yamashita et al, 2005;
Faham et al, 2008; Fang et al, 2009; Gao et al, 2009; Ressl et al,
2009; Shaffer et al, 2009; Schulze et al, 2010; Tang et al, 2010;
Kowalczyk et al, 2011; Ma et al, 2012; Perez et al, 2012). It can be
speculated that this is one of the reasons for the more rigid move-
ment of the two domains with respect to one another in Mhp1 than
is so far apparent for other members of the 5HIRT family (Shimamura
et al, 2010; Krishnamurthy & Gouaux, 2012; Perez et al, 2012).
A B
C D
Figure 5. Structure of wild-type Mhp1 with bound L-NMH.
A Docking pose of L-NMH illustrated using SPROUT as for Fig 1.
B Comparison of the crystal structure of L-NMH (green) with the outward-open ligand-free structure (grey) and the complex with L-IMH (coloured as in Fig 1).
C, D Potential hydrogen bonding interactions between L-NMH and the protein as in Fig 1.
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In going from outward-open to occluded, the sodium symporters
LeuT and BetP and the antiporter AdiC all show a movement of the
hash motif relative to the bundle as observed for Mhp1. However,
in these proteins, there is more flexing of the helices of the bundle
domain around the breakpoints of TMH1 and TMH6 where the rela-
tive substrates bind (Gao et al, 2010; Krishnamurthy & Gouaux,
2012; Perez et al, 2012). The competitive inhibitor tryptophan holds
LeuT in the outward-facing conformation preventing this transition
(Singh et al, 2008). As we have performed for Mhp1 with NMH, a
simple mutation in LeuT can convert tryptophan into a substrate
(Piscitelli & Gouaux, 2012) although this mutation occurs on TMH8
rather than TMH10. Indeed, as might be expected for different
substrates, the occlusion mechanism varies from one transporter to
another and only Mhp1 shows such a dramatic movement of
TMH10. In BetP and AdiC, the movement is much more subdued
(Gao et al, 2010; Perez et al, 2012), and in LeuT, there is very little
difference in its position amongst the various crystal structures
(Krishnamurthy & Gouaux, 2012). In fact, amongst all the solved
structures of the 5HIRT superfamily, the conformation of TMH10
seen in the occluded and inward-facing forms of Mhp1 is only
observed in the inward-facing vSGLT (Faham et al, 2008). Thus,
although the core fold is similar amongst these proteins, the details
of substrate recognition and the conformational changes that occur
upon substrate binding differ. This study, combined with recent
observations on other members of the family, is revealing how
transporters of the 5HIRT family evolved to recognise different
substrates (and cations) and implement symport, antiport or uniport
functions while retaining underlying similarities in protein fold and
molecular mechanism of translocation.
In summary, by combining crystallography with molecular
dynamics, genetic manipulation, biochemical/biophysical assays,
and, importantly, computational and synthetic chemistry, we have
been able to analyse the exquisite precision by which Mhp1
recognises substrates and discover more potent ligands. Further-
more, we have described a novel intermediate conformation of
the protein and shown that transport cannot be effected without
closure of the external thin gate. These insights will expand
further our understanding of the effectiveness of known antimy-
cotic (Paluszynski et al, 2006; Chen et al, 2011) and antibacterial
(Imperi et al, 2013) drugs as well as promote the development of
novel microbial pathways for syntheses of chiral compounds
(Bommarius et al, 1998; Altenbuchner et al, 2001; Suzuki et al,
2005; Matcher et al, 2012).
Materials and Methods
Cell growth and expression of the Mhp1 protein
For subsequent purification of Mhp1 protein for fluorescence
measurements, cells of Escherichia coli BL21(DE3) transformed with
plasmid pSHP11 encoding the hyuP gene from Microbacterium
liquefaciens AJ3912 were cultivated and induced for expression of
Mhp1 as described previously (Suzuki & Henderson, 2006) but in
larger scale 30 or 100 litre fermenters. Details are described in
Supplementary Methods. Expression and purification of Mhp1 for
cocrystallisation with ligands is described in detail in Supplemen-
tary Methods. For small-scale growth of the same cells for subse-
quent measurements of uptake of radioisotope-labelled compounds,
a variation on the procedure for growth, induction, harvesting, wash-
ing and resuspension was adopted, and the details are described in
Supplementary Methods.
Assays of uptake of radioisotope-labelled compounds
14C-labelled compound, generally L-IMH (Patching, 2011), (50 lM
final concentration) was added to the cells in 150 mM NaCl, 5 mM
MES pH 6.6, and the appearance of radioactivity in the cells was
measured after 15 s and 2 min. For competition assays, unlabelled
compound (500 lM) was added 3 min beforehand. The mean radio-
activity was converted to nmol/mg dry mass at each time point and
expressed as percentage of the controls without unlabelled
compound. In selected cases dose–response curves were obtained,
which allowed apparent IC50 values to be generated using Graph-
Pad Prism 6 software.
Synthesis of selected ligands
Synthesis of D/L-NMH, BVH, D/L-IMH, D/L-BH, para-methyl-D/
L-BH, para-ethyl-D/L-BH and para-propyl-DL-BH followed a simple
1- or 2-step procedure (Supplementary Figs S8 and S9). Condensation
Figure 6. Scheme for binding of ligands and transport by the Mhp1
protein.
Upon binding to the outward-open conformation of Mhp1 (1) both the
substrate IMH (right) and the inhibitor NMH (left) induce a number of
conformational changes to the protein. The hash motif (yellow) moves towards
the bundle (red), and Trp117 and Trp220 rotate to interact with the ligand
(denoted by arrows A, B and C respectively). This results in a partial occlusion of
the outward cavity, shown here by a solid line approximately defining the
entrance to the cavity from the outside. A conformational change of TMH10 (D)
results in the complete occlusion of the substrate in the binding site (3), and
subsequently, the protein switches to the inward-facing form. For NMH (2*),
TMH10 cannot adopt the position observed for NMH and transport does
not occur. The scheme has been based on the crystal structures of
states 1, 2* and 3.
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of the appropriate aldehyde with hydantoin followed by hydrogena-
tion of the alkene moiety gave the desired 5-substituted hydantoin
as a racemic mixture. The geometry of the synthesised alkenes was
determined to be Z by reference to published NMR studies
(Thenmozhiyal et al, 2004).
The enantiomerically pure hydantoin derivatives D-NMH,
L-NMH, L-IMH, D-IMH, p-methyl-L-BH, p-methyl-D-BH, L-BH and
D-BH were synthesised by condensation of the appropriate a-amino
acid with potassium cyanate via the N-carbamoyl-a-amino acid
(Supplementary Methods). A 14C-labelled version of L-NMH was
synthesised by including [14C]potassium cyanate in the reaction
mixture (Supplementary Methods).
Protein crystallisation and structure determination
Crystals of IMH-Mhp1, BH-Mhp1, BVH-Mhp1, NMH-Mhp1 were
grown essentially as previously described (Shimamura et al, 2008,
2010; Weyand et al, 2008). Details of crystallisation, data collection
and structure refinement are in Supplementary Methods.
Determination of dissociation constant, Kd, for binding
of ligands to Mhp1
In principle kinetic constants for binding of ligands to Mhp1 can be
determined by measuring changes in fluorescence (DF) of its trypto-
phan residues in response to titration of the protein with a test ligand
in a suitable buffer (10 mM Tris pH 7.6, 0.05% DDM, 2% DMSO,
15 mM NaCl and 125 mM choline chloride with 140 lg/ml Mhp1 at
18°C) under steady-state conditions (Weyand et al, 2008). In prac-
tice, in order to overcome interference by absorption of the ligand
itself, titrations were performed and DF was measured by a stopped-
flow non-equilibrium method, details of which are given in Supple-
mentary Methods with example binding curves shown in Supplemen-
tary Fig S6. In the case of mutations in Trp117 and Trp220, as both
are likely to contribute to the fluorescence change seen when ligands
bind, measurement of transport is a more reliable indicator of their
roles in function than fluorimetric measurements of ligand binding.
Molecular dynamics simulations
The ligands L-BH, L-IMH and L-NMH were parameterised with the
OPLS-AA force field (Rizzo & Jorgensen, 1999) and the MOL2FF
algorithm (Beckstein & Iorga, unpublished). Equilibrium MD
simulations of each ligand molecule in water were performed at
T = 300 K and P = 1 bar with Gromacs 4.5.3 (Hess et al, 2008) for
100 ns (L-BH, L-NMH) or 200–500 ns (L-IMH). The free energy
landscape in the dihedral angles was created with the MDAnalysis
tool kit (Michaud-Agrawal et al, 2011) as described in Supplemen-
tary Methods. MD simulations of conformations of the Mhp1 protein
with L-BH or L-IMH bound followed our previous work (Shimamura
et al, 2010) with some differences as described in Supplementary
Methods. Briefly, the OPLS-AA force field (Rizzo & Jorgensen, 1999)
was used for protein, ligands and POPC lipids. The system was
simulated at constant temperature (310 K) and pressure (1 bar) and
a free NaCl concentration of ~100 mM. Multiple simulations were
carried out with different initial conformations of the ligand. For
analysis, hydrogen bonds were detected by a geometric criterion
with hydrogen-acceptor distance ≤ 3.5 A˚ and the bond angle < 30°.
Design and selection of novel ligands for Mhp1
Compounds were designed using the SPROUT de novo design
program (Law et al, 2003). The original crystal structure of the
ligand-bound Mhp1 complex (PDB code: 2JLO) was used as
the basis for new templates. New templates were designed using the
Maestro molecular modelling environment (www.schrodinger.com/
productpage/14/12/). These were then docked into the Mhp1
crystal structure using the electronic high-throughput screening
programme eHiTS (Zsoldos et al, 2006), which utilises an exhaus-
tive systematic search algorithm that considers all docking poses
that lack severe steric clashes with the protein. Compounds were
chosen for synthesis based upon their predicted binding affinity to
the protein as determined using the eHiTS and SPROUT scoring
functions and also their predicted binding pose, as visualised using
the SPROUT protein boundary surface representation.
Accession codes
Protein Data Bank: the newly acquired crystal structures for IMH-
Mhp1, BH-Mhp1, BVH-Mhp1 and NMH-Mhp1 are deposited under
access codes 4d1a, 4d1b, 4d1c and 4d1d, respectively.
Supplementary information for this article is available online:
http://emboj.embopress.org
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